- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Solid Tumors With HER3 Abnormalities
Total 2176 results
-
Taiho Oncology, Inc.TerminatedAdvanced Solid Tumors With HER2 Abnormalities | Advanced Solid Tumors With HER3 AbnormalitiesUnited States, Spain, France, United Kingdom
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
Jiangsu HengRui Medicine Co., Ltd.RecruitingHER2-expressing Advanced Solid TumorsChina
-
Chinese PLA General HospitalFudan UniversityRecruitingHER2 Positive Advanced Solid TumorsChina
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingHER2-positive Advanced Solid TumorsChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Advanced Solid TumorsChina
-
Krankenhaus NordwestTerminatedHer2/Neu Positive Advanced Solid TumorsGermany
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingPatients With Advanced Solid TumorsChina
-
Gustave Roussy, Cancer Campus, Grand ParisRecruiting
-
Cancer Institute and Hospital, Chinese Academy...RecruitingPatients With Advanced Solid TumorsChina
-
Beijing InnoCare Pharma Tech Co., Ltd.Not yet recruitingPatients With Advanced Solid TumorsChina
-
Bio-Thera SolutionsGeorge Clinical Pty LtdActive, not recruiting
-
Beijing Tide Pharmaceutical Co., LtdRecruitingPatients With Advanced Solid TumorsChina
-
PharmaMarRecruitingPatients With Advanced Solid TumorsSpain
-
Shanghai Changzheng HospitalNot yet recruitingAdvanced Solid Tumors With Neuroendocrine Differentiation
-
Sichuan Kelun Pharmaceutical Research Institute...RecruitingSelected Subjects With Advanced Solid TumorsChina
-
Tianjin Hemay Oncology Pharmaceutical Co., LtdRecruitingPatients With Advanced Stage Solid TumorsChina
-
Hangzhou Adcoris Biopharmacy Co., LtdEnrolling by invitationHER2-positive Advanced Solid TumorChina
-
D3 Bio (Wuxi) Co., LtdRecruitingAdvanced Solid Tumors With MAPK Pathway MutationsAustralia, China, United States
-
Bliss Biopharmaceutical (Hangzhou) Co., LtdActive, not recruitingLocally Advanced/Metastatic HER2 Positive Solid TumorsChina, United States
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownPatients With Advanced or Metastatic Solid TumorsFrance
-
Suzhou Genhouse Bio Co., Ltd.Not yet recruitingPatient With Advanced Solid TumorChina
-
D3 Bio (Wuxi) Co., LtdRecruitingHER-2 Positive Advanced Solid TumorsAustralia, United States, China
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
IconOVir BioRecruitingPatients With Advanced Solid TumorsUnited States
-
Disphar International B.V.CompletedPatients With Advanced or Metastatic Solid Tumors
-
GeneQuantum Healthcare (Suzhou) Co., Ltd.RecruitingHER2 Expressing or Mutated Advanced Malignant Solid TumorsChina
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
Suzhou Genhouse Bio Co., Ltd.Shanghai East Hospital; Shandong Tumor HospitalRecruitingAdvanced Solid Tumors With MAPK Signal Pathway MutantChina
-
Deciphera Pharmaceuticals LLCTerminatedMetastatic Solid Tumors | Locally Advanced Tumors | Cancers With MET Genomic Alterations | Cancers With TRK Genomic AlterationsUnited States
-
BeiGeneCompletedFor Participants With Advanced Solid Tumors Failed With Previous Lines of TreatmentAustralia
-
Washington University School of MedicineMolecular Templates, Inc.WithdrawnHER2-positive Solid Tumor | HER-2 Positive Cancer
-
AstraZenecaDaiichi Sankyo Co., Ltd.Active, not recruitingAdvanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,BreastItaly, Spain, United States, France, Korea, Republic of, Japan, Canada, Denmark, Belgium
-
Tianjin Medical University Second HospitalJiangsu HengRui Medicine Co., Ltd.UnknownSolid Tumor | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein OverexpressionChina
-
Chinese PLA General HospitalUnknownAdvanced HER-2 Positive Solid Tumors | Chemotherapy Refactory | HER-2 Antibody Inhibitor Therapy RefactoryChina
-
Jiangsu Simcere Pharmaceutical Co., Ltd.RecruitingAdvanced or Metastatic Solid Tumors With NTRK, ROS1 or ALK Gene FusionChina
-
AmgenActive, not recruitingAdvanced/Metastatic Solid Tumors With KRAS p.G12C MutationTaiwan, Hong Kong
-
Aadi Bioscience, Inc.Active, not recruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmUnited States, Korea, Republic of, Puerto Rico
-
Turning Point Therapeutics, Inc.TerminatedAdvanced Solid Tumor | Metastatic Solid Tumor | KRAS Mutation-Related TumorsUnited States
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
NantCell, Inc.CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced Malignancy
-
Hoffmann-La RocheCompletedSolid Tumors, Advanced Solid TumorsUnited States
-
Esperance Pharmaceuticals IncCompletedAdvanced Solid Tumors | Solid TumorsUnited States
-
Genentech, Inc.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Korea, Republic of, United States, Brazil, Australia, Argentina, Spain, New Zealand, Poland
-
Frontier Medicines CorporationRecruitingColorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Unresectable Solid Tumor | KRAS G12C | Advanced Solid Tumors With KRAS G12C MutationsUnited States
-
Incyte Biosciences Japan GKCompletedAdvanced Solid Tumors | Metastatic Solid TumorsJapan
-
Memorial Sloan Kettering Cancer CenterKyowa Hakko Kirin Pharma, Inc.CompletedAdvanced Solid Tumors | Metastatic Solid TumorsUnited States
-
Bristol-Myers SquibbCompletedAdvanced Solid Tumors | Metastatic Solid TumorsKorea, Republic of, Canada, Australia